185.83
price down icon0.38%   -0.70
pre-market  Pre-market:  185.54   -0.29   -0.16%
loading
Becton Dickinson Co stock is traded at $185.83, with a volume of 1.54M. It is down -0.38% in the last 24 hours and down -0.12% over the past month. Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$186.53
Open:
$187.93
24h Volume:
1.54M
Relative Volume:
0.81
Market Cap:
$53.26B
Revenue:
$21.39B
Net Income/Loss:
$1.61B
P/E Ratio:
33.42
EPS:
5.5609
Net Cash Flow:
$2.55B
1W Performance:
-1.73%
1M Performance:
-0.12%
6M Performance:
-9.11%
1Y Performance:
-22.12%
1-Day Range:
Value
$185.71
$188.52
1-Week Range:
Value
$185.71
$193.43
52-Week Range:
Value
$163.33
$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Name
Name
Becton Dickinson Co
Name
Phone
(201) 847-6800
Name
Address
ONE BECTON DR, FRANKLIN LAKES
Name
Employee
74,000
Name
Twitter
@BDandCo
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
BDX's Discussions on Twitter

Compare BDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
185.83 53.46B 21.39B 1.61B 2.55B 5.5609
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
546.51 195.43B 9.61B 2.77B 2.27B 7.555
Medical Instruments & Supplies icon
RMD
Resmed Inc
259.49 38.71B 5.15B 1.40B 1.65B 9.5082
Medical Instruments & Supplies icon
ALC
Alcon Inc
76.08 37.70B 10.03B 1.07B 1.39B 2.1549
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
297.47 22.09B 2.96B 487.70M 344.00M 6.6758

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-25-25 Initiated RBC Capital Mkts Sector Perform
May-22-25 Downgrade Citigroup Buy → Neutral
May-02-25 Downgrade Goldman Buy → Neutral
May-02-25 Downgrade Piper Sandler Overweight → Neutral
May-02-25 Downgrade Raymond James Outperform → Mkt Perform
May-01-25 Downgrade BofA Securities Buy → Neutral
May-01-25 Downgrade Wells Fargo Overweight → Equal Weight
May-01-25 Downgrade William Blair Outperform → Mkt Perform
Oct-01-24 Upgrade Citigroup Neutral → Buy
May-30-24 Initiated Goldman Buy
Jul-24-23 Upgrade Raymond James Mkt Perform → Outperform
May-30-23 Resumed Morgan Stanley Overweight
May-05-23 Upgrade Piper Sandler Neutral → Overweight
Apr-12-23 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jan-03-23 Upgrade BofA Securities Neutral → Buy
Dec-12-22 Upgrade Citigroup Sell → Neutral
Jul-11-22 Downgrade Citigroup Neutral → Sell
Jun-24-22 Upgrade Wells Fargo Equal Weight → Overweight
Mar-18-22 Resumed Raymond James Mkt Perform
Mar-02-22 Resumed BofA Securities Neutral
Dec-08-21 Downgrade Piper Sandler Overweight → Neutral
Aug-06-21 Downgrade JP Morgan Overweight → Neutral
May-25-21 Initiated Barclays Equal Weight
Dec-15-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-15-20 Downgrade Wells Fargo Overweight → Equal Weight
Jul-09-20 Upgrade Barclays Equal Weight → Overweight
Jun-01-20 Resumed Goldman Buy
Mar-05-20 Initiated Citigroup Neutral
Feb-07-20 Downgrade Cowen Outperform → Market Perform
Feb-07-20 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20 Downgrade Raymond James Strong Buy → Outperform
Feb-06-20 Downgrade Cowen Outperform → Market Perform
Jan-08-20 Downgrade Barclays Overweight → Equal Weight
May-13-19 Upgrade Barclays Equal Weight → Overweight
Dec-07-18 Initiated Deutsche Bank Buy
Oct-16-18 Initiated Barclays Equal Weight
Jun-21-18 Upgrade JP Morgan Neutral → Overweight
Apr-10-18 Upgrade Citigroup Neutral → Buy
Jan-19-18 Resumed BofA/Merrill Buy
Jan-05-18 Upgrade Citigroup Sell → Neutral
Jan-05-18 Initiated KeyBanc Capital Mkts Overweight
Jan-03-18 Initiated Evercore ISI Outperform
Dec-29-17 Reiterated Deutsche Bank Buy
View All

Becton Dickinson Co Stock (BDX) Latest News

pulisher
Oct 26, 2025

Will Becton Dickinson and Company stock outperform Dow Jones2025 Sector Review & Daily Oversold Bounce Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Technical signs of recovery in Becton Dickinson and CompanyJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is Becton Dickinson and Company (BOX) stock a buy during volatile markets2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is Becton Dickinson and Company (BOX) stock inflation resilientMarket Performance Summary & Proven Capital Preservation Tips - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is Becton Dickinson and Company meeting your algorithmic filter criteriaJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Should you hold or exit Becton Dickinson and Company nowSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Will Becton Dickinson and Company stock profit from fiscal stimulusWall Street Watch & Long-Term Investment Growth Plans - newser.com

Oct 24, 2025
pulisher
Oct 24, 2025

Becton Dickinson Gives South West Blood Bikes a New Permanent Home in Plymouth - Plymouth Chronicle

Oct 24, 2025
pulisher
Oct 23, 2025

What Makes Becton Dickinson & Co. (BDX) a Good Investment? - MSN

Oct 23, 2025
pulisher
Oct 23, 2025

Becton, Dickinson & Co. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo

Oct 23, 2025
pulisher
Oct 23, 2025

Becton, Dickinson and Company Stock: Is Wall Street Bullish or Bearish? - MSN

Oct 23, 2025
pulisher
Oct 23, 2025

Here's What to Expect From Becton, Dickinson & Company’s Next Earnings Report - inkl

Oct 23, 2025
pulisher
Oct 23, 2025

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Will Becton Dickinson and Company see short term momentumMarket Trend Review & Real-Time Volume Analysis Alerts - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

BD simplifies at-home HPV testing with new self-collection solution By Investing.com - Investing.com South Africa

Oct 22, 2025
pulisher
Oct 22, 2025

BD simplifies at-home HPV testing with new self-collection solution - Investing.com Australia

Oct 22, 2025
pulisher
Oct 22, 2025

BD (NYSE: BDX) unveils IVDR-certified at-home HPV self-collection with 30-day stability - Stock Titan

Oct 22, 2025
pulisher
Oct 21, 2025

Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch

Oct 21, 2025
pulisher
Oct 21, 2025

Long term hold vs stop loss in Becton Dickinson and CompanyMarket Growth Review & AI Driven Price Forecasts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

BD launches AI-powered Incada Platform for healthcare connectivity - Medical Device Network

Oct 21, 2025
pulisher
Oct 21, 2025

Is Becton Dickinson and Company stock a fit for income portfoliosJuly 2025 Catalysts & Advanced Technical Signal Analysis - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Waters-Becton, Dickinson deal cleared to close in Brazil - MLex

Oct 20, 2025
pulisher
Oct 20, 2025

Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand - Seeking Alpha

Oct 20, 2025
pulisher
Oct 20, 2025

BD launches AI-enabled platform to connect medical devices By Investing.com - Investing.com Australia

Oct 20, 2025
pulisher
Oct 20, 2025

BD launches AI-enabled platform to connect medical devices - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

What to do if you’re stuck in Becton Dickinson and CompanyAnalyst Downgrade & Daily Price Action Insights - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Nearly 3M connected BD devices — BD's Incada™ AI Platform and Pyxis™ Pro unify device data - Stock Titan

Oct 20, 2025
pulisher
Oct 20, 2025

Becton, Dickinson and Company (BDX) Stock Analysis: Evaluating a 10.14% Potential Upside - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 18, 2025

Published on: 2025-10-19 00:28:03 - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Becton Dickinson's CFO to depart - MSN

Oct 17, 2025
pulisher
Oct 17, 2025

Sell Signal: Will Becton Dickinson and Company stock benefit from green energy trends2025 Trade Ideas & Free Safe Capital Growth Stock Tips - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Published on: 2025-10-18 04:48:02 - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch

Oct 17, 2025
pulisher
Oct 16, 2025

RBC Capital reiterates Sector Perform rating on Becton Dickinson stock By Investing.com - Investing.com Canada

Oct 16, 2025
pulisher
Oct 16, 2025

Evaluating Becton Dickinson and Company with trendline analysisNew Guidance & Smart Investment Allocation Insights - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Becton Dickinson stock falls on weak Q4 sales, CFO departure news - Investing.com Canada

Oct 16, 2025
pulisher
Oct 16, 2025

Becton Dickinson stock falls on weak Q4 sales, CFO departure news By Investing.com - Investing.com South Africa

Oct 16, 2025
pulisher
Oct 16, 2025

BD CFO Set To Exit Company This December, Stock Falls - Benzinga

Oct 16, 2025
pulisher
Oct 16, 2025

Exclusive: Ulta Beauty's new CFO is a Johnson & Johnson veteran tasked to help lead the company's next chapter - Fortune

Oct 16, 2025
pulisher
Oct 16, 2025

Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $200 - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $211 - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

RBC Capital reiterates Sector Perform rating on Becton Dickinson stock - Investing.com

Oct 16, 2025
pulisher
Oct 16, 2025

CFO to leave Becton Dickinson after four years - medwatch.com

Oct 16, 2025
pulisher
Oct 16, 2025

BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190 - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

U.S. Stocks Movement | Becton Dickinson & Co Drops Over 3% Pre-Market Despite Q4 Revenue Growth; Lowers Full-Year Sales Outlook - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

Becton Dickinson Delivers Steady Growth But Misses Revenue Mark - Finimize

Oct 16, 2025
pulisher
Oct 15, 2025

BD announces CFO transition plan, preliminary Q4 results - MassDevice

Oct 15, 2025
pulisher
Oct 15, 2025

BD Announces CFO Transition Plan - citybiz

Oct 15, 2025
pulisher
Oct 15, 2025

Becton Dickinson Posts Preliminary 4Q, FY Results - 富途牛牛

Oct 15, 2025
pulisher
Oct 15, 2025

Becton, Dickinson (BDX) Faces Revenue Projections Below Expectat - GuruFocus

Oct 15, 2025

Becton Dickinson Co Stock (BDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_instruments_supplies RMD
$259.49
price down icon 2.18%
medical_instruments_supplies ALC
$76.08
price down icon 0.24%
medical_instruments_supplies WST
$297.47
price down icon 3.18%
$73.99
price up icon 0.14%
medical_instruments_supplies COO
$73.51
price down icon 1.36%
Cap:     |  Volume (24h):